SG64919A1 - Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides - Google Patents
Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptidesInfo
- Publication number
- SG64919A1 SG64919A1 SG1996008589A SG1996008589A SG64919A1 SG 64919 A1 SG64919 A1 SG 64919A1 SG 1996008589 A SG1996008589 A SG 1996008589A SG 1996008589 A SG1996008589 A SG 1996008589A SG 64919 A1 SG64919 A1 SG 64919A1
- Authority
- SG
- Singapore
- Prior art keywords
- pct
- date
- pseudopeptides
- sec
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13882093A | 1993-10-15 | 1993-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG64919A1 true SG64919A1 (en) | 1999-05-25 |
Family
ID=22483811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996008589A SG64919A1 (en) | 1993-10-15 | 1994-10-17 | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5866685A (fr) |
| EP (1) | EP0812205B1 (fr) |
| JP (1) | JP3032297B2 (fr) |
| KR (1) | KR100304332B1 (fr) |
| CN (1) | CN1135717A (fr) |
| AT (1) | ATE199727T1 (fr) |
| AU (1) | AU703854B2 (fr) |
| BG (1) | BG63166B1 (fr) |
| BR (1) | BR9407839A (fr) |
| CA (1) | CA2174097C (fr) |
| CZ (1) | CZ291378B6 (fr) |
| DE (1) | DE69426897T2 (fr) |
| DK (1) | DK0812205T3 (fr) |
| ES (1) | ES2155122T3 (fr) |
| FI (1) | FI961634A (fr) |
| GR (1) | GR3035581T3 (fr) |
| HK (1) | HK1006225A1 (fr) |
| HU (1) | HU222248B1 (fr) |
| NO (1) | NO961460L (fr) |
| NZ (1) | NZ275948A (fr) |
| PL (1) | PL181749B1 (fr) |
| PT (1) | PT812205E (fr) |
| RO (1) | RO115520B1 (fr) |
| RU (1) | RU2134695C1 (fr) |
| SG (1) | SG64919A1 (fr) |
| SK (1) | SK47796A3 (fr) |
| UA (1) | UA44258C2 (fr) |
| WO (1) | WO1995010295A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780590A (en) * | 1993-10-15 | 1998-07-14 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| US6274705B1 (en) | 1996-05-02 | 2001-08-14 | Aventis Pharmaceuticals Products Inc. | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| ATE199727T1 (de) * | 1993-10-15 | 2001-03-15 | Rhone Poulenc Rorer Pharma | Antithrombotisch wirkende azacycloalkyl-alkanoyl- peptide und-pseudopeptide |
| AU733591B2 (en) * | 1996-08-21 | 2001-05-17 | Aventis Pharmaceuticals Inc. | Stable non-hygroscopic crystalline form of N-(N-N-(4-(piperidin-4-yl)butanoyl)-N-ethylglycyl) compounds |
| IL129877A (en) * | 1996-11-27 | 2004-08-31 | Aventis Pharm Prod Inc | A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent |
| WO1999019294A1 (fr) * | 1997-05-14 | 1999-04-22 | Aventis Pharmaceuticals Products Inc. Legal/Patents | Preparation des pseudotetrapeptides azacycloalkylalcanoyles |
| ZA989241B (en) * | 1997-10-10 | 1999-06-04 | Rhone Poulenc Rorer Pharma | Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| AU2844800A (en) * | 1998-12-30 | 2000-07-24 | Aventis Pharmaceuticals Products Inc. | Process for preparing a stable non-hygroscopic crystalline n-(n-(n- piperdin- 4-yl)butanoyl)- n.ethylglycyl)- (l)-aspartyl) -ss-cyclohexylalanine amide |
| CN101735307B (zh) * | 2008-11-18 | 2012-05-30 | 北京航空航天大学 | 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用 |
| EP3524235A1 (fr) * | 2012-06-11 | 2019-08-14 | The Cleveland Clinic Foundation | Traitement et prévention des maladies cardiovasculaires et de la thrombose |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
| FR2608160B1 (fr) * | 1986-12-15 | 1989-03-31 | Inst Nat Sante Rech Med | Nouveaux derives peptidiques et leur application notamment en therapeutique |
| US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
| US5037808A (en) * | 1988-07-20 | 1991-08-06 | Monsanto Co. | Indolyl platelet-aggregation inhibitors |
| US4879313A (en) * | 1988-07-20 | 1989-11-07 | Mosanto Company | Novel platelet-aggregation inhibitors |
| US4992463A (en) * | 1988-07-20 | 1991-02-12 | Monsanto Company | Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation |
| US5023233A (en) * | 1989-07-28 | 1991-06-11 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| CA2066047A1 (fr) * | 1989-09-29 | 1991-03-30 | Scott I. Klein | Peptides et pseudo-peptides antiplaquettaires |
| US5051405A (en) * | 1989-10-10 | 1991-09-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptides and pseudopeptides |
| US5064814A (en) * | 1990-04-05 | 1991-11-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
| IL99539A0 (en) * | 1990-09-27 | 1992-08-18 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical compositions containing them |
| AU661659B2 (en) * | 1991-04-11 | 1995-08-03 | Rhone-Poulenc Rorer International (Holdings) Inc. | Anti-thrombotic peptide and pseudopeptide derivatives |
| ATE199727T1 (de) * | 1993-10-15 | 2001-03-15 | Rhone Poulenc Rorer Pharma | Antithrombotisch wirkende azacycloalkyl-alkanoyl- peptide und-pseudopeptide |
-
1994
- 1994-10-17 AT AT95900403T patent/ATE199727T1/de not_active IP Right Cessation
- 1994-10-17 PT PT95900403T patent/PT812205E/pt unknown
- 1994-10-17 DK DK95900403T patent/DK0812205T3/da active
- 1994-10-17 SG SG1996008589A patent/SG64919A1/en unknown
- 1994-10-17 AU AU81237/94A patent/AU703854B2/en not_active Ceased
- 1994-10-17 RU RU96109375/04A patent/RU2134695C1/ru not_active IP Right Cessation
- 1994-10-17 CA CA002174097A patent/CA2174097C/fr not_active Expired - Fee Related
- 1994-10-17 SK SK477-96A patent/SK47796A3/sk unknown
- 1994-10-17 EP EP95900403A patent/EP0812205B1/fr not_active Expired - Lifetime
- 1994-10-17 UA UA96051845A patent/UA44258C2/uk unknown
- 1994-10-17 PL PL94313975A patent/PL181749B1/pl unknown
- 1994-10-17 CZ CZ19961084A patent/CZ291378B6/cs not_active IP Right Cessation
- 1994-10-17 HU HU9600983A patent/HU222248B1/hu not_active IP Right Cessation
- 1994-10-17 JP JP7512250A patent/JP3032297B2/ja not_active Expired - Fee Related
- 1994-10-17 RO RO96-00812A patent/RO115520B1/ro unknown
- 1994-10-17 CN CN94194242A patent/CN1135717A/zh active Pending
- 1994-10-17 WO PCT/US1994/012135 patent/WO1995010295A1/fr active IP Right Grant
- 1994-10-17 KR KR1019960701992A patent/KR100304332B1/ko not_active IP Right Cessation
- 1994-10-17 DE DE69426897T patent/DE69426897T2/de not_active Expired - Lifetime
- 1994-10-17 BR BR9407839A patent/BR9407839A/pt not_active Application Discontinuation
- 1994-10-17 NZ NZ275948A patent/NZ275948A/en unknown
- 1994-10-17 ES ES95900403T patent/ES2155122T3/es not_active Expired - Lifetime
- 1994-10-17 US US08/628,648 patent/US5866685A/en not_active Expired - Lifetime
-
1996
- 1996-04-12 NO NO961460A patent/NO961460L/no not_active Application Discontinuation
- 1996-04-12 FI FI961634A patent/FI961634A/fi unknown
- 1996-04-26 BG BG100544A patent/BG63166B1/bg unknown
-
1998
- 1998-06-16 HK HK98105458A patent/HK1006225A1/xx not_active IP Right Cessation
-
2001
- 2001-03-15 GR GR20010400194T patent/GR3035581T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU93054168A (ru) | Димер молекулярного варианта аро-липопротеина, способ его получения, фармацевтическая композиция на его основе | |
| WO2001078709A3 (fr) | Traitement des maladies neurodegeneratives | |
| BG103521A (en) | Substituted pyrimidinon and pyridon compounds and methods for their application | |
| FR2699077B1 (fr) | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. | |
| CA2288143A1 (fr) | Formulations de proteine activee | |
| IL112111A (en) | Peptides having growth hormone releasing properties and pharmaceutical compositions containing them | |
| HU9600983D0 (en) | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | |
| UA26973A1 (uk) | Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів | |
| DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| EP1538163A3 (fr) | Protéine Beta-Amyloide 1-43 Phosphorylée et son Utilisation pour le Traitment de la Maladie d'Alzheimer | |
| SG67928A1 (en) | Antithrombotic | |
| BG103512A (en) | Substituted pyramidine compounds and their application | |
| MXPA03011502A (es) | Aminoalcoholes sustituidos utiles en tratamiento de enfermedad de alzheimer. | |
| CA2140010A1 (fr) | Regulation de la coagulation du sang a l'aide d'un produit contenant du tcf-ii comme ingredient actif | |
| CA2179857A1 (fr) | Medicaments pour la prevention ou le traitement des lesions d'ischemie-perfusion repetee | |
| BG102079A (en) | Alkylaminoderivatives of substituted quinoxalin-2,3-dions such as glutamatereceptor antagonists | |
| CA2065889A1 (fr) | Augmentation du debit choroidien | |
| CA2135752A1 (fr) | Utilisation de la (e)-2-(p-fluorophenethyl)-3-fluoroallylamine dans le traitement de la maladie d'alzheimer | |
| GR3031254T3 (en) | Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same | |
| ES2058025A1 (es) | Aplicacion del acido fitico y/o sus fitatos en los estados patologicos y prepatologicos derivados de la litiasis renal oxalocalcica idiopatica. | |
| CA2060333A1 (fr) | Utilisation de derives de la pyrimidobenzothiazine | |
| RU95104302A (ru) | Аппликационный материал лечебно-профилактического назначения | |
| IT1264562B1 (it) | Composizione farmaceutica per l'applicazione topica di 17,b estradiolo nel trattamento della cheratocongiuntivite sicca |